Total Payments
$1,098
2024 Payments
$55.33
Companies
14
Transactions
84
Medicare Patients
3,102
Medicare Billing
$177,426
Payment Breakdown by Category
Food & Beverage$1,091 (99.3%)
Education$7.64 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,091 | 73 | 99.3% |
| Education | $7.64 | 2 | 0.7% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
General
$1,098
75 transactions
Ownership
$0
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $852.75 | 59 | $0 (2020) |
| Amgen Inc. | $44.36 | 3 | $0 (2017) |
| Boston Scientific Corporation | $36.35 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $32.02 | 1 | $0 (2023) |
| UroGPO LLC | $22.69 | 5 | $0 (2020) |
| MEDIVATION INC. | $19.98 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $18.98 | 1 | $0 (2024) |
| NeoTract Inc. | $16.50 | 1 | $0 (2017) |
| Endo Pharmaceuticals Inc. | $12.82 | 1 | $0 (2019) |
| Mallinckrodt LLC | $11.72 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $55.33 | 5 | Boston Scientific Corporation ($36.35) |
| 2023 | $32.02 | 2 | AstraZeneca Pharmaceuticals LP ($32.02) |
| 2022 | $3.82 | 2 | Travere Therapeutics, Inc. ($3.82) |
| 2021 | $0 | 1 | SN Holdings, LLC |
| 2020 | $30.30 | 4 | Janssen Biotech, Inc. ($26.48) |
| 2019 | $272.68 | 21 | Janssen Biotech, Inc. ($259.86) |
| 2018 | $358.97 | 25 | Janssen Biotech, Inc. ($336.28) |
| 2017 | $345.18 | 24 | Janssen Biotech, Inc. ($230.13) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: LithoVue_URO | ||||||
| 08/15/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: LithoVue_URO | ||||||
| 08/06/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Oncology | ||||||
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 11/08/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $32.02 | General |
| Category: Oncology | ||||||
| 2023 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 05/04/2022 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 2022 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 2021 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 04/07/2020 | Travere Therapeutics, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 03/06/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Oncology | ||||||
| 02/24/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Oncology | ||||||
| 2020 | UroGPO LLC | — | — | — | $0.00 | Ownership |
| 12/13/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Oncology | ||||||
| 12/13/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Oncology | ||||||
| 11/15/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Oncology | ||||||
| 10/10/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Oncology | ||||||
| 10/10/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Oncology | ||||||
| 09/14/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Oncology | ||||||
| 09/14/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Oncology | ||||||
| 08/15/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: Oncology | ||||||
| 08/13/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Oncology | ||||||
| 08/13/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: Oncology | ||||||
| 07/10/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 882 | 5,015 | $263,703 | $49,534 |
| 2022 | 22 | 710 | 3,118 | $205,576 | $39,205 |
| 2021 | 19 | 775 | 5,231 | $253,826 | $44,903 |
| 2020 | 21 | 735 | 5,919 | $252,975 | $43,785 |
Total Patients
3,102
Total Services
19,283
Medicare Billing
$177,426
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 180 | $68,400 | $14,980 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 100 | 112 | $30,240 | $6,917 | 22.9% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 28 | 28 | $27,270 | $5,580 | 20.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 47 | 61 | $42,227 | $3,553 | 8.4% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 11 | 11 | $15,577 | $3,347 | 21.5% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 13 | 13 | $9,900 | $2,537 | 25.6% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 15 | 15 | $11,205 | $2,422 | 21.6% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 20 | 27 | $8,592 | $1,898 | 22.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $8,736 | $1,584 | 18.1% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 13 | 13 | $5,212 | $1,466 | 28.1% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 11 | 11 | $9,992 | $1,254 | 12.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 109 | 130 | $7,930 | $975.80 | 12.3% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 47 | 3,995 | $3,995 | $468.25 | 11.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 107 | 133 | $1,995 | $450.51 | 22.6% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 17 | 18 | $1,334 | $336.23 | 25.2% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 65 | 83 | $1,328 | $327.02 | 24.6% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 21 | 24 | $1,633 | $308.34 | 18.9% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 28 | 37 | $1,073 | $292.67 | 27.3% |
| 87088 | Bacterial urine culture | Office | 2023 | 18 | 28 | $784.00 | $222.04 | 28.3% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 18 | 28 | $588.00 | $221.76 | 37.7% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 16 | 25 | $600.00 | $212.00 | 35.3% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 13 | 13 | $4,706 | $141.21 | 3.0% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 14 | 14 | $386.00 | $39.89 | 10.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 155 | $57,475 | $13,028 | 22.7% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 12 | 14 | $19,278 | $4,157 | 21.6% |
About Dr. Mark Carson, MD
Dr. Mark Carson, MD is a Urology healthcare provider based in Springfield, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780604454.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Carson, MD has received a total of $1,098 in payments from pharmaceutical and medical device companies, with $55.33 received in 2024. These payments were reported across 84 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,091).
As a Medicare-enrolled provider, Carson has provided services to 3,102 Medicare beneficiaries, totaling 19,283 services with total Medicare billing of $177,426. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Springfield, OR
- Active Since 07/19/2006
- Last Updated 09/28/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1780604454
Products in Payments
- Erleada (Drug) $566.81
- ZYTIGA (Drug) $259.46
- Prolia (Biological) $44.36
- LithoVue (Device) $36.35
- LYNPARZA (Drug) $32.02
- ERLEADA (Drug) $26.48
- XTANDI (Drug) $19.98
- PLUVICTO (Drug) $18.98
- Urolift - UL400 (Device) $16.50
- XIAFLEX (Biological) $12.82
- OFIRMEV (Drug) $11.72
- FIRMAGON (Drug) $11.26
- TECENTRIQ (Biological) $11.23
- (815) Thiola (Drug) $3.82
- Thiola (Drug) $3.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Springfield
Bryan Mehlhaff, Md, MD
Urology — Payments: $1.5M
Urology $1.5M
Kevin Mcvary, Md, MD
Urology — Payments: $405,504
Urology $405,504
Bradley Schwartz, M.d, M.D
Urology — Payments: $105,537
Urology $105,537
Robert Nadler, Md, MD
Urology — Payments: $93,691
Urology $93,691
Kevin Krughoff
Urology — Payments: $54,104
Urology $54,104
Dr. Eric Espinosa
Urology — Payments: $23,023
Urology $23,023